Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push
In This Article:
Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs.
Terms and Privacy Policy